RxDoctor Payments Data

Greg Friedman, MD

Psychiatry · Hallandale Beach, FLNPI 1275531543

Payments from drug & device makers

$437,264in general payments, 2019–2025

Across 2,291 payments — averaging $190.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$198K
  • Idorsia Pharmaceuticals US Inc$122K
  • Teva Pharmaceuticals USA, Inc.$92K
  • Bioxcel Therapeutics, Inc.$4K
  • E.r. Squibb & Sons, L.L.C.$4K
  • Janssen Scientific Affairs, LLC$2K
  • plus $15K from 38 others

What the payments were for

  • Consulting fees$12,0503%
  • Speaking & faculty fees$320,97373%
  • Travel & lodging$67,92516%
  • Food & beverage$35,9858%
  • Education$3320%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$437,264 in reported general payments places this provider in the 95th percentile of 2,059 psychiatry providers in Florida.

See all psychiatry providers in Florida

Medicare billing

Part B allowed, 2024
$5,765
Medicare patients
28
Services billed
65

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IgalmiDexmedetomidine Hcl52$172,263
Invega SustennaPaliperidone Palmitate21$54,461
Abilify MaintenaAripiprazole17$49,162
FanaptIloperidone22$30,649
VraylarCariprazine Hcl11$17,066
QuviviqDaridorexant Hcl14$6,953
Quetiapine Fumarate260$2,885
Mirtazapine176$2,638
Trazodone Hcl244$2,344
Risperidone208$2,039
Benztropine Mesylate153$1,873
Olanzapine89$1,842
Aripiprazole48$1,715
Clozapine23$1,607
Hydroxyzine Pamoate111$1,328

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Bioxcel Therapeutics, Inc.Igalmi$3,632$172,26352 claims
Johnson & JohnsonInvega Sustenna$1,818$54,46121 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$235$49,16217 claims
Vanda Pharmaceuticals Inc.Fanapt$1,713$30,64922 claims
AbbVieVraylar$197,999$17,06611 claims
Idorsia Pharmaceuticals US IncQuviviq$122,356$6,95314 claims
Almatica Pharma LLCSertraline Hcl$928$1,234161 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,059 psychiatry providers in Florida.

Other psychiatry in Hallandale Beach

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →